MBNL Fibrosis CMS Actin Myositis Muscle regeneration Mouse model Laminopathie Fabry disease Thymus Autoantibodies Brain Male Autoimmune diseases Transgenic mouse model Glutamate CRISPRi Duchenne muscular dystrophy Myotonic dystrophy type 1 Exercise Long read sequencing Motoneuron Congenital muscular dystrophy Outcome measures Dystrophin Treatment Animals Regeneration DMD Cytoskeleton Myotonic Dystrophy type 1 Thérapie génique Biomarkers Laminopathy Congenital myopathy Biomarker Humans CTG repeat contractions Errance diagnostique Spinal muscular atrophy Therapy RNA interference Calcium Mechanotransduction Dynamin 2 Genotype phenotype correlation Cardiomyopathy Laminopathies Neuromuscular diseases Myotonic dystrophy Cytokines Aged Antisense oligonucleotides Autophagy Muscular dystrophy RNA biology Inflammation Amyotrophic lateral sclerosis Dilated cardiomyopathy Aging Myopathy Myasthenia gravis LMNA gene LMNA AAV Heart Rare diseases Trinucleotide repeat expansion Autoimmunity Transcriptomics Mice Satellite cell Lamin A/C Satellite cells Myopathies OPMD Astrocyte Neuromuscular junction COVID-19 Myasthenia Gravis MG Centronuclear myopathy Rare neuromuscular diseases Becker muscular dystrophy Myogenesis Skeletal muscle FSHD Heart failure Myotonic Dystrophy Muscle Myoblasts Dermatomyositis PABPN1 Lamin A/C LMNA gene Cell therapy Neuromuscular disease Gene therapy ALS Nuclear envelope Genetics Alternative splicing